Recent Advances in the Management of Gastrointestinal Cancer: Focus on Precision Medicine

Last Modified: August 21, 2013

Share article


Dates: December 13, 2013
Location: The Hub Cira Center, 2929 Arch Street, Mezzanine Level, Philadelphia, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania and Perelman School of Medicine at the University of Pennsylvania

Topics Covered

Rare tumors of the GI tract and personalized therapy

Objectives

At the completion of this course, participants should be able to:

  1. Summarize the latest information in the management of neuroendocrine tumors
  2. Understand adjuvant and neoadjuvant treatment options for gastrointestinal cancers
  3. Identify prognostic markers for future diagnostic and treatment options for gastrointestinal cancers
  4. Discuss genomic testing for personalized therapies that alters patients' treatment and prognosis
  5. Assess the current status of translational research in cancer genetics for treatment and prevention
  6. Identify targeted interventions, such as protons and personalized therapy for the treatment of gastrointestinal cancers

Who Should Attend

This course is designed for primary care physicians, gstroenterologists, surgical, medical, and radiation oncologists, endocrinologists, interventional diagnostic radiologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with gastrointestinal cancers.

Registration Information: To request a brochure, please contact Mary M. Graham at grahamm@mail.med.upenn.edu Registration will begin in October.

Fees: $50 physicians, $25 nurses and other healthcare providers

Continuing Education: Yes

Audience: HCP

Miscellany: This course has been approved for CME and CE credits.